Connected Drug Delivery Devices Market Report 2035: Bigfoot, Biocorp, Medtronic
The connected drug delivery devices market, currently valued at $4.4 billion, is predicted to experience substantial growth, with a...
Alzheimer’s Drugs Market to Hit $9.2B by 2030: Global Overview & CAGR
The global market for Alzheimer’s drugs is poised for significant growth, projected to reach $9.2 billion by 2030, reflecting...
Acadia Sells Rare Pediatric Disease Voucher for $150M
Acadia Pharmaceuticals has finalized an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $150 million....
Exact Sciences Q3 2024 Results: Surprising Growth
Exact Sciences Corp. (Nasdaq: EXAS), a prominent cancer screening and diagnostics company, reported third-quarter 2024 revenue of $709 million,...
Tempus Q3 2024 Results & Ambry Acquisition
Tempus AI, Inc. (NASDAQ: TEM), a technology company driving AI adoption in precision medicine and patient care, released its...
Immunis Studies Canine Muscle Atrophy
Immunis, a clinical-stage biotech company, has launched non-terminal safety studies for canine muscle atrophy in partnership with VetBio Partners....
Enveric Biosciences: Broad Range of Patents Issued
Enveric Biosciences, a biotechnology company focused on developing novel neuroplastogens for neuropsychiatric disorders, has significantly expanded its patent protection....
Vertex Reports Strong Q3 2024 Financial Results
Vertex Pharmaceuticals reported strong third-quarter 2024 financial results and raised its full-year product revenue guidance. The company anticipates continued...
Allurion’s Obesity Data from 19,428 Patients Revealed
Allurion Technologies, a company focused on combating obesity, presented two abstracts at Obesity Week 2024. The first abstract showcased...
Scholar Rock Announces Preclinical Data for SRK-439
Scholar Rock, a late-stage biopharmaceutical company, has released promising preclinical data for SRK-439, an investigational anti-myostatin antibody. The data...